Live Breaking News & Updates on Who gmp

Stay informed with the latest breaking news from Who gmp on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Who gmp and stay connected to the pulse of your community

IPCA Labs, Cadila Healthcare among 16 Indian pharma firms blacklisted in Nepal

Kathmandu: In a major setback, Nepal has banned import of medicines from 16 Indian pharmaceutical companies including IPCA Laboratories, Cadila Healthcare, Baba Ramdev promoted Divya Pharmacy for...

Gambia , Kathmandu , Bagmati , Nepal , India , Cadila-healhcare , Baba-ramdev , Patanjali-ayurved , Captab-biotec , Dial-pharmaceuticals , Daffodils-pharmaceuticals-ltd , Zee-laboratories-ltd

DRDO invites EoI to transfer technology of 2-DG drug for bulk production

The 2-DG was developed by the Institute of Nuclear Medicine and Allied Sciences, a lab of DRDO, in collaboration with Dr. Reddy’s Laboratories.

Technical-assessment-committee , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , Active-pharmaceutical-ingredient , Drug-licensing-authorities , Defence-research-and-development-organisation , Drdo , 2-dg

Patanjali Ayurved Acharya Balkrishna coronil IMA remarks Health Minister Dr Harsh Vardhan

URL copied
Balkrishna defends Coronil, wants doctors' association to withdraw remarks
In his response to Indian Medical Association (IMA), Acharya Balkrishna, Patanjaliâs managing director on Wednesday released a statement clarifying that Coronil has been awarded the CoPP licence as per WHO-GMP. He asserted that Union Health Minister Dr Harsh Vardhan didn't endorse any ayurvedic medicine and neither did he undermine modern medicines.Â
Earlier this week, IMA had expressed shock over the "blatant lie of WHO certification" for Patanjali's Coronil tablet, which the company claimed is an evidence-based medicine to fight COVID-19. The association also demanded an explanation from the union health minister in whose presence the medicine was launched.

Patanjali-coronil , Southeast-asia , Acharya-balkrishna , Union-health , Ayush-ministry , World-health-organization , Indian-medical-association , Central-drugs-standard-control-organisation , Image-source , Union-health-minister-dr-harsh-vardhan , Swami-ramdev , Pharmaceutical-product

LASA receives WHO Nod for its Khed Unit in Ratnagiri

LASA receives WHO Nod for its Khed Unit in Ratnagiri
ANI |
Updated: Jan 12, 2021 18:19 IST
"WHO Good Manufacturing Practice certificate can be obtained by constant efforts towards improving the quality assurance as well as implementation of various systems on place, though we already have GMP for our other major units, we are also proud to receive this recognition for our Unit Located in Khed with the efforts of our Hardworking Team," said Dr Omkar Herlekar, Chairman - Lasa Supergenerics Limited, commenting on the development.
WHO GMP covers all aspects of production starting from the materials, premises and equipment to the training and personal hygiene of staff. Detailed, written procedures which are essential for each process that could affect the quality of the finished product. Systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process - every time a product is made.

Australia , Bangladesh , Mumbai , Maharashtra , India , Mahad , Egypt , China , Chiplun , Turkey , Jordan , Omkar-herlekar